Clinical Operations
Phase I–IV clinical trials and observational studies are supported across the Middle East, Africa, Pakistan, and the EAEU, enabling reliable trial execution from start-up to close-out.
- Rat/Mouse PINP EIA
- IDS-iSYS PTH (1-34)
- Corticosterone EIA
- Corticosterone HS
- Urine CartiLaps EIA
- Rat/Mouse PINP EIA
- IDS-iSYS PTH (1-34)
- Corticosterone EIA
- Corticosterone HS
- Urine CartiLaps EIA
Our feasibility services help you:
- Anticipate local challenges: Identify operational and protocol-related risks and implement mitigation strategies
- Understand patient flows: Analyze local healthcare systems to optimize enrollment and study organization
- Navigate regulations: Align protocols with country-specific requirements to support efficient approvals
We select high-performing sites and investigators based on:
- Staff experience and availability
- Site infrastructure, equipment and capabilities
- Historical performance and patient access
We offer on-site, remote, and hybrid monitoring models, adapted to study design, risk level, and regulatory requirements.
Our monitoring teams are trained to ensure protocol compliance, data quality, and patient safety, while keeping sites aligned with study objectives throughout the clinical trial lifecycle.
Monitoring Services Include
- Qualification Visits – Assess site readiness and capabilities
- Site Initiation Visits – Prepare site staff and ensure protocol understanding
- Interim Monitoring Visits – Track progress, data quality, and compliance
- Close-Out Visits – Ensure proper study completion and documentation
- Site Management – Ongoing support and communication to quickly address challenges
We provide ongoing support to ensure sites and investigators run trials efficiently. We train site staff, resolve operational issues, maintain clear communication, and oversee accurate study documentation.
We manage vendor selection and oversight, ensuring partners meet quality, compliance, and international standards while keeping studies on track.